- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Pharmacological intervention
- Antivirals
- Corticosteroid
- Baloxavir
- Oseltamivir
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Fragile population
- Immunocompromised host
- People living with HIV
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Hospital
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Plasma
- Adults (18-64 years)
- General population
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Statins
- Adults (18-64 years)
- General population
- Hospital
- SARS-CoV-2
- Blood sample
- PBMC
- Whole blood
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Stool sample
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Non pharmacological intervention
- Convalescent plasma
- Adults (18-64 years)
- Elderly (≥65 years)
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Non-hospital health centre
- STD/STI clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- HIV
- Mycoplasma genitalium
- Hepatitis
- Anorectal swab
- Oral swab
- Urethral exudate
- Pharmacological intervention
- PrEP-HIV
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- People at high risk of STIs
- PrEP users
- Hospital
- Community
- Primary care
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- Pharmacological intervention
- PrEP-bSTI
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Hantavirus
- Puumala virus
- Blood sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- SARS-CoV-2
- Influenza-like illness/Acute respiratory infection
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Non-hospital health centre
- STD/STI clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- Adults (18-64 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Pharmacological intervention
- Immunomodulator
- Corticosteroid
- Baloxavir
- Oseltamivir
- General population
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Intensive care unit
- Respiratory syncytial virus
- Adults (18-64 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Blood sample
- Urine sample
- Hair
- Saliva
- Semen
- Vaginal fluids
- Adults (18-64 years)
- People at high risk of STIs
- Hospital
- Outpatient clinic
- Monkeypox virus
- Blood sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Influenza virus
- Streptococcus pneumoniae
- Influenza-like illness/Acute respiratory infection
- Pharmacological intervention
- Vaccination
- General population
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Group A Streptococcus
- Influenza A virus
- Influenza B virus
- Influenza-like illness/Acute respiratory infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Pregnant women
- Community
- Chlamydia trachomatis
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- Influenza-like illness/Acute respiratory infection